November 6, 2026 · The American journal of sports medicine · DOI: 10.1177/03635465261498163

A Single Intra-articular Injection of Autologous Stromal Vascular Fraction for Moderate-to-Severe Knee Osteoarthritis: Results of a Multicenter Randomized Placebo-Controlled Trial With 12-Month Follow-up.

Listen to this summary

This randomized, placebo-controlled trial asked whether a single intra-articular injection of 25 million autologous adipose-derived stromal vascular fraction (SVF) cells, prepared at the point of care during the same visit, improves pain and function in moderate-to-severe knee osteoarthritis at 12 months. Among 114 randomized patients (83 SVF, 31 placebo), the responder rate was significantly higher with SVF (51.8% vs. 29%; difference 22.8%, 1-sided P = .0149), and no serious device-related adverse events were reported. The findings suggest SVF provides statistically superior and clinically meaningful symptom relief over placebo at one year, though the modest sample size and 1-sided analysis warrant cautious interpretation.

Jaime R Garza, Claude T Moorman, Michael Baria, Daniel Santa Maria, Jay Bowen, Neil Sparks, J Peter Rubin

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play